Fagron N.V. buy melinda
Start price
06.02.18
/
50%
€10.02
Target price
07.02.18
€11.40
Performance (%)
16.17%
End price
07.02.18
€11.64
Summary
This prediction ended on 07.02.18 with a price of €11.64. The BUY prediction by melinda finished with a performance of 16.17%. melinda has a follow-up prediction for Fagron N.V. where he still thinks Fagron N.V. is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fagron N.V. | 3.425% | 3.425% | 17.367% | 5.942% |
| iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
| iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
| iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
| iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by melinda for this prediction
In the thread Fagron N.V. diskutieren
Pharmazeutische SecteurProduits Agenda 07/02 Ergebnisse Veröffentlichung
Die geographische Verteilung des Umsatzes sieht wie folgt aus: Belgien (8%), Europa (51,5%), Lateinamerika (21,6%), USA (18,1%) und sonstiges (0,8%).
Anzahl der Mitarbeiter: 1.991 Personen.